Near Misdiagnosis of Glioblastoma as Primary Central Nervous System Lymphoma

Por Bhatt, Vijaya Raj, Shrestha, Rajesh, Shonka, Nicole, Bociek, R. Gregory
Publicado em 2014

Demographic and other characteristics of nodal non-Hodgkin’s lymphoma managed in academic versus non-academic centers

Por Bhatt, Vijaya Raj, Dhakal, Prajwal, Dahal, Sumit, Giri, Smith, Pathak, Ranjan, Bociek, R. Gregory, Silberstein, Peter T., Armitage, James O.
Publicado no Ther Adv Hematol (2015)

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL

Por Shukla, Ashima, Rai, Karan, Shukla, Vipul, Chaturvedi, Nagendra K., Bociek, R. Gregory, Pirruccello, Samuel J., Band, Hamid, Lu, Runqing, Joshi, Shantaram S.
Publicado no Blood (2016)

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia

Por Mittal, Amit K., Chaturvedi, Nagendra K., Rohlfsen, Rae A., Gupta, Payal, Joshi, Avadhut D., Hegde, Ganapati V., Bociek, R. Gregory, Joshi, Shantaram S.
Publicado em 2013

Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

Por Loberiza, Fausto R., Cannon, Anthony J., Weisenburger, Dennis D., Vose, Julie M., Moehr, Matt J., Bast, Martin A., Bierman, Philip J., Bociek, R. Gregory, Armitage, James O.
Publicado em 2009

ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma

Por Batlevi, Connie Lee, Kasamon, Yvette, Bociek, R. Gregory, Lee, Peter, Gore, Lia, Copeland, Amanda, Sorensen, Rachel, Ordentlich, Peter, Cruickshank, Scott, Kunkel, Lori, Buglio, Daniela, Hernandez-Ilizaliturri, Francisco, Younes, Anas
Publicado no Haematologica (2016)

CELL-OF-ORIGIN FAILS TO PREDICT SURVIVAL IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Por Gu, Keni, Weisenburger, Dennis D, Fu, Kai, Chan, Wing C, Greiner, Timothy C, Aoun, Patricia, Smith, Lynette M, Bast, Martin, Liu, Zhongfen, Bociek, R. Gregory, Bierman, Philip J, Armitage, James O, Vose, Julie M
Publicado no Hematol Oncol (2011)

Phase II Study of Mocetinostat (MGCD0103) In Patients with Relapsed and Refractory Classical Hodgkin Lymphoma

Por Younes, Anas, Oki, Yasuhiro, Bociek, R. Gregory, Kuruvilla, John, Fanale, Michelle, Neelapu, Sattva, Copeland, Amanda, Buglio, Daniela, Galal, Ahmed, Besterman, Jeffrey, Li, Zuomei, Drouin, Michel, Patterson, Tracy, Ward, M. Renee, Paulus, Jessica K., Ji, Yuan, Medeiros, L. Jeffrey, Martell, Robert E.
Publicado no Lancet Oncol (2011)

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Por LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O’Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Publicado no Blood (2018)